Panacea Biotec Limited is an India-based biotechnology company. The Company is engaged in producing vaccines. The Company operates in three segments: Vaccines, Formulations, and Research & Development Activities. The Company's products reach approximately 35 countries worldwide. The Company’s portfolio of vaccines includes the Trivalent Oral Polio Vaccine (tOPV), Monovalent (Type I and Type III) Oral Polio Vaccine (mOPV), Enivac HB (Hepatitis B) Vaccine, and combination vaccines, such as Ecovac4 (Diphtheria-Tetanus-wholecell Pertusis (DTwP)-Hepatitis B), Easyfour (DTwP-Haemophilus Influenza type B (Hib)) and Easyfive (DTwP-Hepatitis B-Hib).